Electrical Brain Stimulation for College Students With Short-Form Video Addiction: Effects and Mechanisms
NCT07931729, Not applicable, Not yet recruiting, Beijing Normal University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Electrical Brain Stimulation for College Students With Short-Form Video Addiction: Effects and Mechanisms | ClinicalTrials.gov |
| NCT number | NCT07931729 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 82 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Beijing Normal University | ClinicalTrials.gov |
| Conditions | Short-form Video Addiction | ClinicalTrials.gov |
| Interventions | Active High-Definition Transcranial Direct Current Stimulation (Active HD-tDCS), Sham High-Definition Transcranial Direct Current Stimulation (Sham HD-tDCS) | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Short-form Video Addiction Scale Score | Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention | Assessed using the 25-item Short-form Video Addiction Scale, which includes two dimensions: Addictive Dependence and Negative Consequence. Each item is scored on a 7-point Likert scale (1 = strongly disagree, 7 = strongly agree). The total score ranges from 25 to 175. A higher score indicates a more severe level of short-form video addiction. | ClinicalTrials.gov |
| Primary | Change in Average Daily Short-form Video Use Duration | Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention | Self-reported average time (in minutes) spent watching short-form videos per day over the past week. A higher duration indicates more excessive use. | ClinicalTrials.gov |
| Secondary | Change in Executive Function Composite Score (SSRT & BART) | Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention | A composite executive function score will be derived using Exploratory Factor Analysis (EFA) from two tasks: (1) Stop-Signal Reaction Time (SSRT) from the Stop-Signal Task, and (2) Adjusted Average Pumps (AAP) from the Balloon Analogue Risk Task (BART). The factor score extracted from the EFA will serve as the composite indicator, accounting for the relative weighting of each measure. Factor scores will be oriented such that higher values indicate better overall executive function. | ClinicalTrials.gov |
| Secondary | Change in Emotion-Cognition Composite Score (Craving, ABS, ER) | Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention | A composite emotion-cognition score will be derived using Exploratory Factor Analysis (EFA) from three measures: (1) Craving Score, (2) Attentional Bias Score (ABS) from the dot-probe task, and (3) Emotion Regulation Score. The factor score extracted from the EFA will serve as the composite indicator to capture the shared variance among these measures. Factor scores will be oriented such that higher values indicate more favorable emotional-cognitive outcomes. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Balloon Risk | Secondary outcome | ConductCognition |
| Dot-Probe Task | Secondary outcome | ConductCognition |
| Stop-Signal Task | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)